Main ContentMaRISS
Study title
Mild and rapidly improving stroke symptoms research study (MaRISS)
- Principal Investigator: Dr. Rebecca Sugg
Purpose
This study aims to determine long-term outcomes of patients with mild and rapidly improving stroke and examine the association with tissue plasminogen activator (TPA) treatment.
Who can participate
Those eligible to participate in this study include:
- Those who have experienced a mild ischemic stroke or rapidly improving stroke symptoms.
For more information
- Susan Hetzel
University of Mississippi Medical Center
2500 N. State St.
Jackson, MS 39216
(601) 984-5518 - IRB Number: 2017-0207